Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression of genetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients

ABSTRACT: Series GSE25262 patients on expression side.

ORGANISM(S): Homo sapiens

PROVIDER: GSE37414 | GEO | 2013/02/13

SECONDARY ACCESSION(S): PRJNA159943

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Expression of genetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients

Project description:Series GSE25262 patients on expression side. [Exon study] 11 myeloma patients at diagnosis and relapse examined with Exon expression chip

2013-02-13 | E-GEOD-37414 | biostudies-arrayexpress

Genetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients.

Project description:Purpose Despite advances and significant improvement in survival, multiple myeloma (MM) remains incurable and nearly all patients relapse after treatment. Previous studies have shown a complex spectrum of diverse genetic alterations in almost all patients, but evolution of genomic rearrangements throughout myeloma life cycle has not been investigated. Patients and Methods We performed genomic analysis integrating copy number, allele specific copy number, allele ratio calculations, breakpoint sequencing and rearrangement PCR genotyping on matched diagnosis and relapse samples from 24 MM patients either treated with proteasome inhibitor (bortezomib)-based induction regimen or conventional chemotherapeutic agents. Results All relapse samples have a clear relationship to the diagnosis clone with significant increase of copy number abnormalities (CNAs). Despite a wide diversity of CNAs acquired at relapse, regulators of NF-kB activity were targeted in 25% of the patients. Relapse-associated lesions either appeared as new acquisition or were selected from minor subpopulations at diagnosis. In one third of the patients, we found loss of abnormities containing loss of heterozygosity (LOH) providing evidence that the relapse clone derived from an ancestral clone shared with the dominant diagnosis clone. Remarkably, re-emergence of ancestral clones was almost exclusively found in patients treated with bortezomib, attested to a remarkable adaptability of myeloma cells under targeted drug selection pressure. Conclusion These data suggest that genomic instability and clonal selection are the main forces that drive adaptive changes in MM under drug selection pressure, and they support the proposal to combine several anti-myeloma drugs upfront in order to obtain long-term remissions.

2013-02-13 | GSE25262 | GEO

Genetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients.

2013-02-13 | E-GEOD-25262 | biostudies-arrayexpress

Gene Expression Profiles of Multiple Myeloma Before Treatment

Project description:Samples in this series are pre-treatment bone marrow aspirates from multiple myeloma patients Keywords = CKS1B in Multiple Myeloma, Bone Marrow, Pre-Treatment Keywords: other

2006-06-01 | GSE4204 | GEO

Gene Expression Profiles of Multiple Myeloma (N=414) Before Treatment

Project description:Samples in this series are pre-treatment bone marrow aspirates from multiple myeloma patients Keywords: other

2006-06-01 | GSE4581 | GEO

Gene Expression Profiles of Multiple Myeloma (N=65) Before Treatment

Project description:Samples in this series are pre-treatment bone marrow aspirates from multiple myeloma patients Keywords: other

2006-04-15 | GSE4452 | GEO

Treatment of multiple myeloma.

Project description: Not available

| S-EPMC3773461 | biostudies-literature

Genetic variation within the Mx gene of commercially selected chicken lines reveals multiple haplotypes, recombination and a protein under selection pressure.

Project description: Not available

| S-EPMC4171530 | biostudies-literature

Clonal evolution in multiple myeloma after treatment pressure: heterogenous genomic aberrations and transcriptomic convergence

Project description:Multiple myeloma (MM) is still an incurable plasma cell malignancy that generally responds well to treatment intitially, but eventually becomes refractory. In the present study, genomic and transcriptomic changes were investigated in paired early and late tumor samples of MM patients .

2022-05-01 | GSE179929 | GEO

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.

Project description: Not available

| S-EPMC9252918 | biostudies-literature